Predicate |
Object |
assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_5012bc1ee0f38ae9a5a544dbc0253a0b http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_9bba0a34651fd8cd73cf83e6a9effe12 http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_aeaf260a3ab6ea002b0da85ab55e6e86 http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_82fb320873755cdeb281c87f17727c1f http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_c753d9632e1041b2893b727f2f8aef8e http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_84257a46906e61ef75c31429517a7c42 |
classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-7023 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61N1-30 |
classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P5-38 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P5-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-0009 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-573 |
classificationIPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-70 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61N1-30 |
classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-573 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P5-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-00 |
filingDate |
2004-08-24-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_fa9e3051f99c553f5009e3c4d44c289f http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_cb4eb427c9c1daf29f7dec353b79397e http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_bce3d4a5ea692ccca6d3d3cb964d1841 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_b902ef8ce89d1b8d4592016deefc6554 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_69ffa6212817213552b909267e177a86 |
publicationDate |
2005-03-10-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber |
WO-2005020967-A1 |
titleOfInvention |
Electric drug transport preparation |
abstract |
An electric drug transport preparation in which stability of a drug is enhanced during storage and a variation in appearance (coloring) of a drug holding layer due to metal ions derived from an electrode can be prevented during preparation under such a state that the drug holding layer containing a drug unstable under dissolved state adjoins a nonpolarizable electrode, and a high biological utilization rate of a drug can be attained by preventing adhesion of the electrode component to skin. The electric drug transport preparation (1) comprises an electrode supporting substrate (5), an electrode layer (2) arranged on the electrode supporting substrate (5), a drug holding layer (3) arranged on the electrode layer (2), and a cover material (4) covering the drug holding layer (3). The drug holding layer (3) contains an electrolyte reacting with a metal chelating agent and/or the electrode layer (2) to form a hard-to-dissolve compound. |
priorityDate |
2003-08-29-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type |
http://data.epo.org/linked-data/def/patent/Publication |